a Griffith University Menzies Health Institute Queensland , Alliance for Vascular Access Teaching and Research (AVATAR) , Nathan , Australia.
Expert Rev Mol Diagn. 2017 Feb;17(2):181-188. doi: 10.1080/14737159.2017.1275964. Epub 2017 Jan 2.
intravascular catheter related bloodstream infection (IVC-BSI) is a leading cause of nosocomial infections and associated with significant morbidity and mortality. Early detection and adequate treatment of causative pathogens is critical for a favourable outcome. However, it takes significant time to receive microbiological results due to the current reference diagnostic method's reliance on microbial growth. Areas covered: This review discusses culture and non-culture based techniques for the diagnosis of non IVC-BSI and IVC-BSI, including molecular methods and biomarkers. Different diagnostic strategies are evaluated and the potential of new generation of diagnostic assays highlighted. Expert commentary: The development of additional diagnostic methods has potential to beneficially supplement conventional culture diagnosis, and molecular techniques have particular potential to fulfil this need. They would also contribute significant new knowledge on the bacterial species present on catheters that are generally missed by diagnosis using traditionally culture-dependent methods. Advances in molecular strategies, together with new biomarkers, might lead to the development of faster, more sensitive and cheaper technologies and instruments. This review aims to provide a platform for the further development of IVCBSI diagnostic techniques.
血管内导管相关血流感染(IVC-BSI)是医院感染的主要原因,与严重的发病率和死亡率相关。早期发现和充分治疗病原体对于良好的结果至关重要。然而,由于当前参考诊断方法依赖于微生物生长,因此需要相当长的时间才能获得微生物学结果。
本综述讨论了用于诊断非 IVC-BSI 和 IVC-BSI 的基于培养和非培养的技术,包括分子方法和生物标志物。评估了不同的诊断策略,并强调了新一代诊断检测方法的潜力。
额外诊断方法的开发有可能有益地补充传统的培养诊断,而分子技术尤其有潜力满足这一需求。它们还将为通常通过传统依赖培养的方法进行诊断而错过的导管上存在的细菌种类提供重要的新知识。分子策略的进步以及新的生物标志物可能会导致更快、更敏感和更便宜的技术和仪器的发展。本综述旨在为 IVCBSI 诊断技术的进一步发展提供一个平台。